No. 10 — Federal Preemption After Rescheduling: Conflict, Obstacle, and Cannabis Federalism

No. 10 — Federal Preemption After Rescheduling: Conflict, Obstacle, and Cannabis Federalism

If federal enforcement priorities shift while federal prohibition remains intact, courts will increasingly confront whether the CSA preempts state licensing structures that depend on continued federal forbearance. Whether state laws are argued as exemptions to new and changing federal CSA directives will likely arise in court cases.

By Jason Karimi | WeedPress Policy Series No. 10
February 27 2026

The prior essays examined how cannabis rescheduling could trigger Dormant Commerce Clause challenges and expose structural federalism tensions.

But constitutional friction does not end with interstate discrimination.

If marijuana is rescheduled under the Controlled Substances Act (CSA), courts may confront a second and more intricate question: whether certain state regulatory structures are preempted by federal law.

Rescheduling does not merely change criminal exposure. It may recalibrate the Supremacy Clause balance.

⸻

I. The Supremacy Clause Framework

The Supremacy Clause provides:

“This Constitution, and the Laws of the United States which shall be made in Pursuance thereof… shall be the supreme Law of the Land.”¹

Under this principle, valid federal law prevails where state law conflicts.

The Supreme Court recognizes three primary categories of preemption:
1. Express preemption
2. Field preemption
3. Conflict preemption

See Arizona v. United States, 567 U.S. 387, 399 (2012).²

Conflict preemption includes:

• Impossibility preemption (where compliance with both federal and state law is impossible), and
• Obstacle preemption (where state law stands as an obstacle to federal objectives).³

The purpose of Congress remains “the ultimate touchstone in every pre-emption case.”⁴

⸻

II. Congressional Purpose Under the CSA

The CSA’s findings appear in 21 U.S.C. § 801.

Congress declared:

“Many of the drugs included within this subchapter have a useful and legitimate medical purpose and are necessary to maintain the health and general welfare of the American people.”⁵

Congress further found:

“The illegal importation, manufacture, distribution, and possession and improper use of controlled substances have a substantial and detrimental effect on the health and general welfare of the American people.”⁶

The statute reflects dual objectives:

1. Prevent drug abuse and illicit trafficking;
2. Ensure availability of controlled substances for legitimate medical and scientific use.⁷

In Gonzales v. Raich, 545 U.S. 1 (2005), the Court upheld Congress’s authority to regulate even intrastate marijuana activity under the Commerce Clause. That decision confirmed that federal power over controlled substances remains plenary.

Rescheduling would not diminish that authority, but it may alter the conflict analysis where Congress formally recognizes medical utility.

Rescheduling marijuana to Schedule III would not eliminate federal regulation — but it would formally recognize accepted medical utility within a regulated framework.

That shift affects the federal objective inquiry.

⸻

III. The CSA’s Express Preemption Clause

The CSA contains an explicit savings clause rejecting field preemption:

“No provision of this subchapter shall be construed as indicating an intent on the part of the Congress to occupy the field…”¹

21 U.S.C. § 903 continues:

“…unless there is a positive conflict between that provision of this subchapter and that State law so that the two cannot consistently stand together.”

Two features matter:

• Congress did not intend to occupy the field.
• But it preserved conflict preemption where “positive conflict” exists.

The phrase “so that the two cannot consistently stand together” frames the operative constitutional question.

⸻

IV. Scheduling Authority and Federal Recognition

Rescheduling occurs under 21 U.S.C. § 811.

Section 811(a) provides:

“The Attorney General may by rule… add to such a schedule or transfer between such schedules any drug… if he finds that such drug has a potential for abuse.”⁹

Placement within Schedule III is governed by 21 U.S.C. § 812(b)(3), which defines Schedule III substances as those:

“(A) having a potential for abuse less than the drugs or other substances in schedules I and II,
(B) having a currently accepted medical use in treatment in the United States, and
(C) abuse of the drug… may lead to moderate or low physical dependence…”¹⁰

If marijuana is placed in Schedule III, federal law will formally recognize:

• Currently accepted medical use;
• Regulated manufacture and distribution;
• Federal registration pathways.

That recognition alters the structural relationship between state prohibition models and federal authorization schemes.

⸻

V. Registration and Federal Permission

Registration is governed by 21 U.S.C. § 823.

Section 823(b) provides that the Attorney General shall register an applicant to manufacture a Schedule III substance if registration is “consistent with the public interest.”¹¹

Section 823(f) similarly governs practitioner registration.¹²

If federal law authorizes a registrant to manufacture or distribute a Schedule III substance, and a state law categorically prohibits such federally registered conduct, conflict-preemption questions may arise.

The inquiry becomes:

Does the state rule render federal authorization meaningless?

⸻

VI. Anti-Commandeering and Limits of Preemption

Preemption does not authorize federal commandeering.

In Murphy v. NCAA, 584 U.S. 453 (2018), the Court reaffirmed:

“The anti-commandeering doctrine… prohibits Congress from issuing direct orders to the governments of the States.”¹³

Thus:

• The federal government cannot require states to criminalize marijuana.
• States may decline to enforce federal drug laws.

Rescheduling does not eliminate state autonomy.

But autonomy is distinct from obstruction.

⸻

VII. Conflict and Obstacle Analysis

Under obstacle preemption doctrine:

State law is preempted where it “stands as an obstacle to the accomplishment and execution of the full purposes and objectives of Congress.”¹⁴

If Congress’s objectives include regulated availability of Schedule III substances for legitimate medical use, a state rule that categorically prohibits any federally registered distribution channel may raise obstacle concerns.

However, courts will not lightly infer such conflict.

In Wyeth v. Levine, the Court cautioned:

“The purpose of Congress is the ultimate touchstone.”¹⁵

Section 903’s preservation of state authority suggests that Congress anticipated coexistence between federal and state regimes.

The conflict must be real — not merely policy disagreement.

⸻

VIII. Interaction with Dormant Commerce Clause Doctrine

Preemption and Dormant Commerce Clause analysis are distinct but related.

• DCC concerns discrimination against interstate commerce.
• Preemption concerns incompatibility with federal law.

A residency requirement may violate the DCC even if not preempted.

Conversely, a nondiscriminatory but absolute prohibition could survive DCC scrutiny while still frustrating federal objectives.

Rescheduling could therefore produce:

• Dormant Commerce Clause litigation;
• Supremacy Clause litigation;
• Or both.

⸻

IX. Litigation Pathways

Preemption challenges would proceed in federal district courts.

Potential plaintiffs:

• Federally registered manufacturers;
• Multistate distributors;
• Research institutions;
• Investors excluded by state structures.

Courts would evaluate:

• The scope of federal registration authority under § 823;
• The medical-use determination under § 812(b);
• The savings clause under § 903;
• Congressional purpose under § 801.

Remedies may include declaratory relief or injunction.

⸻

Conclusion

Rescheduling marijuana is often framed as criminal reform or tax reform.

It may instead become a Supremacy Clause inflection point.

The CSA does not occupy the field.

But it does displace state law where “positive conflict” prevents federal and state schemes from standing together.

As cannabis reform advances administratively, the constitutional battleground may shift from agency discretion to structural federalism.

Delegation remains real.
Judicial scrutiny intensifies.
Conflict analysis becomes central.

After scheduling debates conclude, preemption may define the next chapter of cannabis litigation.

⸻

Footnotes
1. U.S. Const. art. VI, cl. 2.
2. Arizona v. United States, 567 U.S. 387, 399 (2012).
3. Id.; Hines v. Davidowitz, 312 U.S. 52, 67 (1941).
4. Wyeth v. Levine, 555 U.S. 555, 565 (2009).
5. 21 U.S.C. § 801(1).
6. 21 U.S.C. § 801(2).
7. Id.
8. 21 U.S.C. § 903.
9. 21 U.S.C. § 811(a).
10. 21 U.S.C. § 812(b)(3).
11. 21 U.S.C. § 823(b).
12. 21 U.S.C. § 823(f).
13. Murphy v. NCAA, 584 U.S. 453, 471 (2018).
14. Hines, 312 U.S. at 67.
15. Wyeth, 555 U.S. at 565.

WeedPress Policy Series

No. 1 — Legal Memorandum: Common Misconceptions in Cannabis Activism Regarding Federal Drug Law (January 25, 2026)

No. 2 — The Path to a Religious Cannabis Exemption: How Medical Cannabis Systems Change the RFRA Equation (January 27, 2026)

No. 3 — Structural Contradictions and Prospective Litigation Risk in Post-Rescheduling Cannabis Policy (February 6, 2026)

No. 4 — The Controlled Substances Act Is Not a Blunt Instrument — It Is an Architecture of Exceptions (February 13, 2026)

No. 5 — The Limits of § 822(d): What It Does — and Does Not — Authorize (February 13, 2026)

No. 6 — The Major Questions Doctrine and Cannabis Reform: Delegation, Scale, and Judicial Review (February 14, 2026)

No. 7 — Chevron’s Collapse and Cannabis Regulation: Judicial Review After Loper Bright (February 17, 2026)

No. 8 — Administrative Procedure Act Vulnerabilities in DEA Rescheduling (February 20, 2026)

No. 9 – No. 9 — Dormant Commerce Clause, Circuit Splits, and Cannabis Federalism (February 23, 2026)

No. 10 — Federal Preemption After Rescheduling: Conflict, Obstacle, and Cannabis Federalism (February 27, 2026)

About Weedpress Policy Series

The Weedpress Policy Series publishes in-depth, citation-supported analysis of federal cannabis law, regulatory policy, and enforcement practices. The series is designed to provide lawmakers, attorneys, journalists, and stakeholders with legally grounded, non-activist, non-promotional analysis focused on statutory reality and institutional accountability.

Weedpress Policy Series emphasizes:

• Federal statutory interpretation
• Congressional intent and legislative history
• Treaty and international law implications
• Administrative law and agency authority
• Oversight of enforcement discretion and regulatory gaps